Serum iron levels as a new biomarker in chemotherapy with leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan, with or without molecularly-targeted drugs

類似資料

• Leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan as individualized first-line therapy based on a drug sensitivity test
  著者:: OCHIAI, TAKUMI, 等
  出版事項: (2010)
• Good response to leucovorin and fluorouracil plus oxaliplatin and cetuximab therapy in a patient with metastatic ascending colon cancer harboring a KRAS p.G13D mutation
  著者:: OCHIAI, TAKUMI, 等
  出版事項: (2012)
• Mechanism underlying the transient increase of serum iron during FOLFOX/FOLFIRI therapy
  著者:: OCHIAI, TAKUMI, 等
  出版事項: (2014)
• Individualized chemotherapy for colorectal cancer based on the collagen gel droplet-embedded drug sensitivity test
  著者:: OCHIAI, TAKUMI, 等
  出版事項: (2012)
• Identification of responders/non-responders to 5-fluorouracil based on individual 50% inhibitory area under the concentration curve of 5-fluorouracil obtained with collagen gel droplet-embedded culture-drug sensitivity test in colorectal cancer
  著者:: OCHIAI, TAKUMI, 等
  出版事項: (2011)